GSK plc (GLAXF)
OTCMKTS · Delayed Price · Currency is USD
23.98
+1.19 (5.22%)
Dec 15, 2025, 4:00 PM EST
GSK plc Employees
GSK plc had 68,629 employees as of December 31, 2024. The number of employees decreased by 1,583 or -2.25% compared to the previous year.
Employees
68,629
Change (1Y)
-1,583
Growth (1Y)
-2.25%
Revenue / Employee
$630,016
Profits / Employee
$107,608
Market Cap
98.09B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 68,629 | -1,583 | -2.25% |
| Dec 31, 2023 | 70,212 | 812 | 1.17% |
| Dec 31, 2022 | 69,400 | -20,696 | -22.97% |
| Dec 31, 2021 | 90,096 | -3,970 | -4.22% |
| Dec 31, 2020 | 94,066 | -5,371 | -5.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| American Oncology Network | 1,914 |
| Jushi Holdings | 1,234 |
| Glass House Brands | 374 |
| Zomedica | 152 |
| Silence Therapeutics | 116 |
| Elite Pharmaceuticals | 68 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
GSK plc News
- 1 day ago - UK approves GSK's twice-yearly asthma drug - Reuters
- 1 day ago - GSK's Nucala for COPD and Depemokimab for Asthma Get CHMP Nod in EU - Nasdaq
- 1 day ago - Dividend Income: Lanny's October 2025 Summary - Seeking Alpha
- 4 days ago - GSK: Depemokimab And Jemperli Lead Next Wave (Rating Upgrade) - Seeking Alpha
- 4 days ago - GSK's $4 Billion Asthma Drug Gets First-Ever Green Light in Europe - GuruFocus
- 4 days ago - GSK Gets FDA Nod for Blujepa in Uncomplicated Urogenital Gonorrhea - Nasdaq
- 4 days ago - GSK Gains CHMP Recommendation for Nucala in COPD Treatment - GuruFocus
- 4 days ago - GSK's Depemokimab Receives CHMP Approval Recommendation for Asthma and CRSwNP - GuruFocus